BioSpace News Archive

Epizyme, Inc. announced the appointments of experienced commercial executive, Grant Bogle, and research and development executive, Victoria Richon, Ph.D., to the company’s board of directors.

NEW ENDPOINT IMPROVES ABILITY TO CONDUCT STUDY MORE EXPEDITIOUSLY WITH SIGNIFICANTLY FEWER PATIENTS Clinical Trial Cost Savings Estimated to Approach $10 million

Merck announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Inlyta, a tyrosine kinase inhibitor, for the first-line treatment of patients with advanced renal cell carcinoma.

Canonic, a fully owned subsidiary of Evogene Ltd. announces that Dr. Arnon Heyman, Canonic’s CEO, will present at CannX, 4th International Medical Cannabis Conference in Tel Aviv, September 9-10, 2019.

SCYNEXIS, Inc. announced that the Company will present in the following investor conferences

Investment to Drive Expansion of Employee Benefit Group Captive Solutions to Help Employers Self-Insure and Save on Healthcare Costs [04-September-2019] PHILADELPHIA and BOSTON , Sept. 4, 2019 /PRNewswire/ -- Pareto Health, Inc. (“Pareto Health”), a leading employee benefit group captive manager that helps businesses with 50+ employees self-fund health benefits wi

A seasoned medical device executive with over 25 years of experience

Schrödinger announced a collaboration with AstraZeneca to deploy Schrödinger’s advanced computing platform to help accelerate drug discovery efforts.

Endo’s operating company Par Pharmaceutical, Inc. expects to distribute the product through specialty pharmacies beginning this month.

Viriom Inc., has won a grant award in the city of Shaoxing, Zhejiang province, to establish its affiliate in Mainland China.